Canadian CANNAINVESTOR Magazine Canadian Publicly Traded April / May 2019 | Page 57

Thanks Louis. Pleasure being here as an avid reader of the magazine.

Good afternoon Dr. Kyle and thank you for taking a few minutes out of your busy schedule today.

You are the CEO at Vireo Health International Inc (“Vireo”). Because Vireo is also our feature company this month our readers can dive into the wealth of content and coverage within this issue and that let’s us get right into it.

Vireo is listed on the Canadian Securities Exchange and trades under the symbol VREO and in the USA trades OTC under the symbol VREOF. Dr. Kyle, before getting into some company specifics, what was it like taking the Reverse Take Over route and what role did Cannabis Growth Opportunity Corporation (CSE:CGOC) play with respect to Vireo?

Our decision to pursue a Reverse Takeover (RTO) really came down to a matter of timing, as traditional IPOs can be more time consuming and regulatorily complex. We have several important strategic initiatives underway this year, and it was our objective to complete our fundraising by the end of calendar Q1 so that we can spend the rest of 2019 focused on execution.

We wouldn’t be in the position we’re in today without the continued support of our shareholders, including the great team at CGOC. We are proud to be a CGOC portfolio company, and they’ve become a true partner whose experience and guidance we value.

They’re obviously proud of Vireo’s performance, and I’d refer everyone to the news release they issued shortly after our RTO to get a better sense for what I’m talking about, but we’ve always taken our responsibility to shareholders seriously and we intend to maintain our commitment to creating value for shareholders as we transition to operating as a public company.

57